Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder is a research paper published in Biological Psychiatry (2020). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Jazz Pharmaceuticals
Grant: NCT02362529
National Institute on Drug Abuse
Grant: DA04066
Canada Research Chairs
Grant: GSD-157948
Canada Research Chairs
Grant: MOP-136955
NIMH NIH HHS
Grant: R01 MH063291
NCRR NIH HHS
Grant: P51 RR000167
NIH HHS
Grant: P51 OD011106
NIH HHS
Grant: P51 OD011107
NIMH NIH HHS
Grant: R01 MH046729
Jazz Pharmaceuticals
Grant: unidentified
unidentified
Janssen Pharmaceuticals
Azrieli Foundation
Brain and Behavior Research Foundation
Canada Foundation for Innovation
Canadian Institutes of Health Research
National Institutes of Health
FWCI
2.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals